非アルコール性脂肪性肝炎（NASH）の世界市場：市場規模・現状・予測

• 英文タイトル：Global Nonalcoholic Steatohepatitis (NASH) Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03956 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、非アルコール性脂肪性肝炎（NASH）の世界市場について調査・分析し、非アルコール性脂肪性肝炎（NASH）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ビタミンE、ピオグリタゾン、オカリバ、エラフィブラノール、セロンサチブ、セニクリビロク）、用途別（病院薬局、オンラインプロバイダー、小売薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の非アルコール性脂肪性肝炎（NASH）市場動向 ・主要企業別マーケットシェア ・非アルコール性脂肪性肝炎（NASH）の種類別市場規模2014-2019 （ビタミンE、ピオグリタゾン、オカリバ、エラフィブラノール、セロンサチブ、セニクリビロク） ・非アルコール性脂肪性肝炎（NASH）の用途別市場規模2014-2019 （病院薬局、オンラインプロバイダー、小売薬局） ・非アルコール性脂肪性肝炎（NASH）の北米市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝炎（NASH）のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝炎（NASH）の中国市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝炎（NASH）の日本国内市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝炎（NASH）の東南アジア市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝炎（NASH）のインド市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝炎（NASH）の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Tobira Therapeutics、Cadila Healthcare、Conatus Pharmaceuticals、Galmed Pharmaceuticals、Gemphire Therapeutics、Genfit、Gilead Sciences、Intercept Pharmaceuticals、Novartis International、Shire） ・非アルコール性脂肪性肝炎（NASH）の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major factors such as higher prevalence of NASH, expected launch of pipeline drugs, and higher number of unmet needs drive the growth of this market. However, poor diagnosis of NASH due to the lack of ideal diagnostic technologies limit the growth of the NASH market.
At present, vitamin E & pioglitazone segment dominates the non-alcoholic steatohepatitis (NASH) market, due to efficacy.
Asia-Pacific presents lucrative opportunities for the key players operating in the non-alcoholic steatohepatitis (NASH) market. Some factors such as growth in diagnostic techniques, rapid rise in prevalence NASH, growth in economies, and increase in demand for NASH therapeutics drive the market growth in Asia-Pacific.
In 2018, the global Nonalcoholic Steatohepatitis (NASH) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Nonalcoholic Steatohepatitis (NASH) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nonalcoholic Steatohepatitis (NASH) development in United States, Europe and China.

The key players covered in this study
Tobira Therapeutics
Cadila Healthcare
Conatus Pharmaceuticals
Galmed Pharmaceuticals
Gemphire Therapeutics
Genfit
Gilead Sciences
Intercept Pharmaceuticals
Novartis International
Shire

Market segment by Type, the product can be split into
Vitamin E & Pioglitazone
Ocaliva
Elafibranor
Selonsertib & Cenicriviroc

Market segment by Application, split into
Hospital Pharmacy
Online Provider
Retail Pharmacy  

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Nonalcoholic Steatohepatitis (NASH) status, future forecast, growth opportunity, key market and key players.
To present the Nonalcoholic Steatohepatitis (NASH) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nonalcoholic Steatohepatitis (NASH) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type (2014-2025)
1.4.2 Vitamin E & Pioglitazone
1.4.3 Ocaliva
1.4.4 Elafibranor
1.4.5 Selonsertib & Cenicriviroc
1.5 Market by Application
1.5.1 Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacy
1.5.3 Online Provider
1.5.4 Retail Pharmacy  
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Nonalcoholic Steatohepatitis (NASH) Market Size
2.2 Nonalcoholic Steatohepatitis (NASH) Growth Trends by Regions
2.2.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (2014-2025)
2.2.2 Nonalcoholic Steatohepatitis (NASH) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Manufacturers
3.1.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Manufacturers (2014-2019)
3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio (CR5 and HHI)
3.2 Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Area Served
3.3 Key Players Nonalcoholic Steatohepatitis (NASH) Product/Solution/Service
3.4 Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019)
4.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019)

5 United States
5.1 United States Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
5.2 Nonalcoholic Steatohepatitis (NASH) Key Players in United States
5.3 United States Nonalcoholic Steatohepatitis (NASH) Market Size by Type
5.4 United States Nonalcoholic Steatohepatitis (NASH) Market Size by Application

6 Europe
6.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
6.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Europe
6.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type
6.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application

7 China
7.1 China Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
7.2 Nonalcoholic Steatohepatitis (NASH) Key Players in China
7.3 China Nonalcoholic Steatohepatitis (NASH) Market Size by Type
7.4 China Nonalcoholic Steatohepatitis (NASH) Market Size by Application

8 Japan
8.1 Japan Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
8.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Japan
8.3 Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Type
8.4 Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
9.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Southeast Asia
9.3 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Type
9.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Application

10 India
10.1 India Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
10.2 Nonalcoholic Steatohepatitis (NASH) Key Players in India
10.3 India Nonalcoholic Steatohepatitis (NASH) Market Size by Type
10.4 India Nonalcoholic Steatohepatitis (NASH) Market Size by Application

11 Central & South America
11.1 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
11.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Central & South America
11.3 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Type
11.4 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Application

12 International Players Profiles
12.1 Tobira Therapeutics
12.1.1 Tobira Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.1.4 Tobira Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.1.5 Tobira Therapeutics Recent Development
12.2 Cadila Healthcare
12.2.1 Cadila Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.2.4 Cadila Healthcare Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.2.5 Cadila Healthcare Recent Development
12.3 Conatus Pharmaceuticals
12.3.1 Conatus Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.3.4 Conatus Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.3.5 Conatus Pharmaceuticals Recent Development
12.4 Galmed Pharmaceuticals
12.4.1 Galmed Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.4.4 Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.4.5 Galmed Pharmaceuticals Recent Development
12.5 Gemphire Therapeutics
12.5.1 Gemphire Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.5.4 Gemphire Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.5.5 Gemphire Therapeutics Recent Development
12.6 Genfit
12.6.1 Genfit Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.6.4 Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.6.5 Genfit Recent Development
12.7 Gilead Sciences
12.7.1 Gilead Sciences Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.7.4 Gilead Sciences Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.7.5 Gilead Sciences Recent Development
12.8 Intercept Pharmaceuticals
12.8.1 Intercept Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.8.4 Intercept Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.8.5 Intercept Pharmaceuticals Recent Development
12.9 Novartis International
12.9.1 Novartis International Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.9.4 Novartis International Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.9.5 Novartis International Recent Development
12.10 Shire
12.10.1 Shire Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.10.4 Shire Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.10.5 Shire Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Nonalcoholic Steatohepatitis (NASH) Key Market Segments
Table Key Players Nonalcoholic Steatohepatitis (NASH) Covered
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type 2014-2025
Figure Vitamin E & Pioglitazone Figures
Table Key Players of Vitamin E & Pioglitazone
Figure Ocaliva Figures
Table Key Players of Ocaliva
Figure Elafibranor Figures
Table Key Players of Elafibranor
Figure Selonsertib & Cenicriviroc Figures
Table Key Players of Selonsertib & Cenicriviroc
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacy Case Studies
Figure Online Provider Case Studies
Figure Retail Pharmacy   Case Studies
Figure Nonalcoholic Steatohepatitis (NASH) Report Years Considered
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2025 (Million US$)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions 2014-2025 (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions 2014-2019 (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions 2014-2019
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions 2014-2019
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions 2019
Table Market Top Trends
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Share by Manufacturers (2014-2019)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share by Manufacturers in 2018
Table Global Nonalcoholic Steatohepatitis (NASH) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nonalcoholic Steatohepatitis (NASH) Product/Solution/Service
Table Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Type (2014-2019)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2014-2019)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Application (2014-2019)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2014-2019)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Application in 2018
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table United States Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table United States Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table United States Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table United States Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table United States Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table United States Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table Europe Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table Europe Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure China Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table China Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table China Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table China Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-20189) (Million US$)
Table China Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table China Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table China Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table Japan Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table Japan Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Japan Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Japan Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure India Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table India Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table India Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table India Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table India Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table India Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table India Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Table Tobira Therapeutics Company Details
Table Tobira Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) (Million US$)
Figure Tobira Therapeutics Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Tobira Therapeutics Recent Development
Table Cadila Healthcare Company Details
Table Cadila Healthcare Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Cadila Healthcare Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Cadila Healthcare Recent Development
Table Conatus Pharmaceuticals Company Details
Table Conatus Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Conatus Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Conatus Pharmaceuticals Recent Development
Table Galmed Pharmaceuticals Company Details
Table Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Galmed Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Galmed Pharmaceuticals Recent Development
Table Gemphire Therapeutics Company Details
Table Gemphire Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Gemphire Therapeutics Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Gemphire Therapeutics Recent Development
Table Genfit Company Details
Table Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Genfit Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Genfit Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Gilead Sciences Recent Development
Table Intercept Pharmaceuticals Company Details
Table Intercept Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Intercept Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Intercept Pharmaceuticals Recent Development
Table Novartis International Company Details
Table Novartis International Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Novartis International Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Novartis International Recent Development
Table Shire Company Details
Table Shire Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Shire Recent Development
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (Million US$) 2019-2025
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Regions (2019-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Regions in 2025
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure China Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure India Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Product (2019-2025) (Million US$)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Product (2019-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Product in 2025
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2025) (Million US$)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---